Irvine, United States
Reverse Medical Corporation, founded in 2007, is a dynamic presence in the Biotechnology, Health Care, and Pharmaceutical sectors. The company's mission, encapsulated in its slogan, "A commercial-stage medical device company dedicated to restoring blood flow in patients with Acute Ischemic Stroke," reflects its dedication to addressing critical medical needs.
Operating as a commercial-stage entity, Reverse Medical specializes in developing advanced medical devices aimed at revascularizing patients affected by Acute Ischemic Stroke. Headquartered in the United States, this company is strategically positioned within one of the world's most significant healthcare markets.
The company secured a $14.00M Series B investment on 07 April 2010, reflecting investor confidence from key players such as Early Stage Partners, Emergent Medical Partners, BioStar Capital, MedFocus Fund, Wexford Capital, and NBGI Ventures. This investment underscores the potential seen in Reverse Medical's innovative solutions in the stroke treatment space.
